Procaps Group S.A. Warrants
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use… Read more
Market Cap & Net Worth: Procaps Group S.A. Warrants (PROCW)
Procaps Group S.A. Warrants (NASDAQ:PROCW) has a market capitalization of $177.16 ($177.16) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #38288 globally and #12460 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Procaps Group S.A. Warrants's stock price $0.02 by its total outstanding shares 9132 (9.13K).
Procaps Group S.A. Warrants Market Cap History: 2019 to 2025
Procaps Group S.A. Warrants's market capitalization history from 2019 to 2025. Data shows change from $3.42K to $177.16 (-42.92% CAGR).
Procaps Group S.A. Warrants Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Procaps Group S.A. Warrants's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Procaps Group S.A. Warrants's market cap is 0.00 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
Procaps Group S.A. Warrants's market cap is 0.00 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $3.42K | $324.79 Million | -$17.01 Million | 0.00x | N/A |
| 2020 | $8.68K | $331.47 Million | -$10.45 Million | 0.00x | N/A |
| 2021 | $7.31K | $409.74 Million | -$100.86 Million | 0.00x | N/A |
| 2022 | $4.24K | $409.92 Million | $42.54 Million | 0.00x | 0.00x |
| 2023 | $1.17K | $414.10 Million | $52.20 Million | 0.00x | 0.00x |
Competitor Companies of PROCW by Market Capitalization
Companies near Procaps Group S.A. Warrants in the global market cap rankings as of March 18, 2026.
Key companies related to Procaps Group S.A. Warrants by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Procaps Group S.A. Warrants Historical Marketcap From 2019 to 2025
Between 2019 and today, Procaps Group S.A. Warrants's market cap moved from $3.42K to $ 177.16, with a yearly change of -42.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $177.16 | -53.59% |
| 2024 | $381.72 | -67.50% |
| 2023 | $1.17K | -72.31% |
| 2022 | $4.24K | -41.95% |
| 2021 | $7.31K | -15.79% |
| 2020 | $8.68K | +153.33% |
| 2019 | $3.42K | -- |
End of Day Market Cap According to Different Sources
On Feb 2nd, 2026 the market cap of Procaps Group S.A. Warrants was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $177.16 USD |
| MoneyControl | $177.16 USD |
| MarketWatch | $177.16 USD |
| marketcap.company | $177.16 USD |
| Reuters | $177.16 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.